VK2735
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Viking Therapeutics · Phase 3 · Active, not recruiting · Enrollment 1100
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo Assignment | Obesity or overweight | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #1) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #2) | Obesity or overweight | n/r | n/r | n/r | n/r |
| Active Assignment (Dose #3) | Obesity or overweight | n/r | n/r | n/r | n/r |